Christina Applegate has delivered a raw and defiant message to the multiple sclerosis community after revealing her 2021 diagnosis was incorrect — yet insisting her solidarity with patients remains unshaken.
The 54-year-old actor, who stepped away from acting in 2022 following the final season of Netflix’s Dead to Me, disclosed the medical reversal last week on MeSsy, the podcast she co-hosts with fellow MS patient Jamie-Lynn Sigler. The show returned after a seven-month hiatus forced by Applegate’s deteriorating health. “I’m still going to speak out on your behalf forever and ever,” she told listeners. “I still feel like part of this community and no matter what I love you.”
A diagnosis reversed, but symptoms persist
The revelation came courtesy of new diagnostic technology, though Applegate described the news as anything but a relief. Her doctor entered the room and offered congratulations: she did not have MS. Applegate’s response was blunt. “You don’t get misdiagnosed and then all of the sudden I’m better. I haven’t got better … If anything, I’ve got worse in some ways. So I’m back at square one, that I don’t know what’s going on with me.”
She is not exaggerating. Days after the announcement, she timed her morning routine. Ten minutes. That is how long it took to move from pillow to standing position. “I don’t know what’s going on. This is what I am still living with,” she said.
The mimicry of autoimmune disease
Applegate’s experience underscores a frustrating reality in neurology. Multiple sclerosis shares clinical features with a host of other autoimmune and neurological conditions — neuromyelitis optica, MOG antibody disease, certain vitamin deficiencies, even some rare genetic disorders. The overlap is significant enough that misdiagnosis rates remain stubbornly high. “There’s a pretty damn high number of misdiagnoses with MS,” Applegate noted. “So this is not a rare occurrence.”
Her next step is a rheumatology referral. If that yields no answers, the specialist carousel begins: another expert, then another. “That starts to overwhelm me… I think I just have to go, all right, one step at a time.”
Sigler on the podcast’s evolving purpose
Jamie-Lynn Sigler, diagnosed with MS in 2016, framed the show’s next chapter with clarity. “This is just about our lives and the messiness of life in general. It was never meant to be solely MS focused.”
She also highlighted the unexpected value of Applegate’s disclosure. “Not even just about a misdiagnosis, but about how difficult it is to get a correct diagnosis, and all of the different types of things, especially autoimmune and neurological that can mimic one of the other, and the frustration that comes along with that, and the heaviness that can come with a diagnosis, and all the feelings around it.”
The conversation, in other words, has outgrown its original label.
Why it Matters
Applegate’s misdiagnosis lays bare a systemic gap: diagnostic certainty in complex autoimmune disease remains elusive, even for patients with resources and visibility. Her refusal to disengage from the MS community — despite no longer belonging to it clinically — transforms a personal medical setback into a public service. By refusing the tidy narrative of “good news,” she forces attention onto the thousands navigating diagnostic limbo, where symptoms are real but labels keep shifting. That visibility may be the most potent medicine of all.
